Kelley Shippey, MD
Sleep Medicine · Kalispell, MTNPI 1245431105
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Eisai Inc. at 34.5% of the total. Reporting peaked in 2020 at $3,671 and has fallen 99.1% since, to $32 in 2025.
Across 109 payments — averaging $75.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$3K
- Inspire Medical Systems, Inc.$3K
- Jazz Pharmaceuticals Inc.$563
- Axsome Therapeutics, Inc.$279
- Johnson & Johnson$271
- Idorsia Pharmaceuticals US Inc$147
- plus $1K from 24 others
What the payments were for
- Speaking & faculty fees$2,55031%
- Travel & lodging$2,15026%
- Food & beverage$3,35741%
- Education$1492%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 8 | $2,827 |
| Inspire Medical Systems, Inc. | 19 | $2,706 |
| Jazz Pharmaceuticals Inc. | 16 | $563 |
| Axsome Therapeutics, Inc. | 6 | $279 |
| Johnson & Johnson | 6 | $271 |
| Idorsia Pharmaceuticals US Inc | 3 | $147 |
| Harmony Biosciences LLC | 3 | $126 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $123 |
| Boehringer Ingelheim | 7 | $115 |
| Sanofi | 1 | $112 |
| Boston Scientific | 2 | $108 |
| Regeneron Healthcare Solutions, Inc. | 1 | $101 |
| ANI Pharmaceuticals, Inc. | 3 | $91 |
| Actelion Pharmaceuticals US, Inc. | 5 | $87 |
| Bayer | 3 | $60 |
| Mylan Specialty L.p. | 3 | $52 |
| Mallinckrodt Hospital Products Inc. | 2 | $50 |
| Resmed Corp | 1 | $49 |
| AstraZeneca(2 entities) | 3 | $47 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $43 |
| Noctrix Health, Inc. | 1 | $42 |
| La Jolla Pharmaceutical Company | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Novartis | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| 3b Medical, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| GSK | 1 | $17 |
| United Therapeutics Corporation | 1 | $15 |
| Aegerion Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few sleep medicine providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 11 | $5,560 |
| Gabapentin | 28 | $540 |
| Trazodone Hcl | 19 | $132 |
| Ropinirole Hcl | 15 | $125 |
| Clonazepam | 19 | $31 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Kalispell
- Deborah HoffmanKalispell$4K
- David AndersonGreat Falls$6K
- Roy KohlerBillings$2K
- Ahmed RashwanMissoula$2K
- Rodolfo SocaBozeman$1K
- Timothy RouxGreat Falls$602
- Kurt KubickaHelena$335
- Sowmini OommanBozeman$145
- Farnaz AbbasimoradiBillings$139
- Frederick ZellerBillings$26
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.